pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
REGENERON PHARMACEUTICALS · news · pharmadog
← back to REGENERON PHARMACEUTICALS
News mentioning REGENERON PHARMACEUTICALS
56
stories
2d
Regeneron racks up another first as FDA greenlights generalized myasthenia gravis RNA drug
biospace
2d
With FDA nod, Regeneron brings an RNAi drug to autoimmune disease
biopharma dive
5d
J&J bets $2.2B on Ollin’s vision loss drug
biopharma dive
8d
Regeneron’s POTS antibody curbs heart rate spikes, teeing up Phase 3 trial
biospace
8d
Regeneron posts positive phase 2 data for baloncibart in nervous system disorder, eyes pivotal trial
fiercebiotech
9d
10 companies hiring in New Jersey
biospace
11d
BioSpace 2027 Best Places to Work shines light on most admired employers
biospace
16d
The top 12 companies hiring in biopharma now
biospace
19d
Earnings roundup: AstraZeneca’s cost cuts, Alnylam’s slump and Regeneron’s resilience
biopharma dive
22d
Regeneron achieves ‘clean sweep’ in Q3 with myriad pipeline catalysts on deck
biospace
23d
8 companies hiring in New York
biospace
Oct 19, 26
EyePoint will halve workforce, end pivotal wet AMD trials early following second fail
biospace
Oct 7, 26
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
biospace
Oct 6, 26
The top biopharma conferences in 2027
biopharma dive
Oct 2, 26
This week in charts: Kodiak’s big comeback and Hengrui’s dealmaking
biopharma dive
Oct 1, 26
Pfizer’s eczema drug clears skin in mid-stage trial
biopharma dive
Oct 1, 26
Sanofi pays Regeneron $1B upfront to continue search for Dupixent successor
biospace
Oct 1, 26
STAT+: Sanofi, Regeneron expand partnership after Dupixent success
stat
Oct 1, 26
Sanofi pays Dupixent partner Regeneron $1B upfront for 4 early-stage assets to ignite R&D
fiercebiotech
Sep 30, 26
PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval
biopharma dive
Sep 28, 26
Kodiak skyrockets on positive study data for 2 eye drugs
biopharma dive
Sep 28, 26
FDA nod for Mirum’s Atebrioz makes 3 options for ultra-rare bone disease
biospace
Sep 28, 26
6 immunology targets to sustain a mammoth I&I market
biospace
Sep 23, 26
9 companies hiring in Pennsylvania now
biospace
Sep 17, 26
Trending: Top biopharma disciplines with jobs live now
biospace
Sep 17, 26
Biopharma hiring hotspots: States, disciplines where demand is highest
biospace
Aug 28, 26
AstraZeneca, Amgen poised to challenge Dupixent’s reign with esophagitis win
biospace
Aug 20, 26
Regeneron to challenge Ipsen as FDA clears bone disease drug
biopharma dive
Aug 20, 26
STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
stat
Aug 19, 26
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
stat
← prev
page 1 of 2
next →